Reagent Red Cell Panel for ABO Reverse Grouping
- UID
- MFG/IVD/2021/000021_dc3e25a97b1f7a3941f3294ce569c87e_8de18ccd5ec88dfa5d9e2462e0a19ae8
- Device class
- Class D
- Brand name
- RPR
- License holder
- TULIP DIAGNOSTICS PRIVATE LIMITED
- Approving authority
- Sub Zonal Goa
- Product information
- Matrix Erygen ABO comprises of a 0.8% reagent red blood cells of A1, B and O suspended in an isotonic medium containing a preservative which is employed in the confirmation of the results of forward grouping
Reagent Red Cell Panel for ABO Reverse Grouping is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000021_dc3e25a97b1f7a3941f3294ce569c87e_8de18ccd5ec88dfa5d9e2462e0a19ae8. This device is marketed under the brand name RPR. The license holder is TULIP DIAGNOSTICS PRIVATE LIMITED, and it is classified as Device Class Class D. The approving authority is Sub Zonal Goa.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.